Global Automated and Closed Cell Therapy Processing Systems Market Set for Expansion as Scalable Workflows Drive Growth, 2026-2033

The global automated and closed cell therapy processing systems market is projected to reach USD 7.0 billion by 2033, expanding at a CAGR of 20.2%. Growth is driven by increasing investment in regenerative medicine, CAR-T cell therapies, and personalized medicine. Non-stem cell therapy leads the type segment, while pre-commercial/R&D-scale applications dominate by scale. North America leads regionally, with LAMEA posting the fastest regional growth at 21.6% CAGR.